Quick Answer
Definitive Healthcare Corp. reported Cash and Equivalents of $163.63 million for fiscal year 2025.
Definitive Healthcare Corp. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $163.63M | +55.3% |
| 2024 | $105.38M | -19.5% |
| 2023 | $130.98M | -10.9% |
| 2022 | $146.93M | -62.1% |
| 2021 | $387.50M | +1464.1% |
| 2020 | $24.77M | +187.5% |
| 2019 | $8.62M | -49.5% |
| 2019 | $17.06M | -11.9% |
| 2018 | $19.36M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $108.32M | -21.3% | +33.8% |
| June 30, 2025 | $80.98M | -33.0% | -23.7% |
| March 31, 2025 | $106.10M | +0.1% | +0.7% |
| December 31, 2024 | $105.38M | -19.5% | -23.4% |
| September 30, 2024 | $137.61M | +77.7% | +13.8% |
| June 30, 2024 | $120.90M | -8.7% | +14.1% |
| March 31, 2024 | $105.99M | -15.2% | -19.1% |
| December 31, 2023 | $130.98M | -10.9% | +69.1% |
- Definitive Healthcare Corp. showed an increase of +55.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, Definitive Healthcare Corp.’s cash and equivalents has grown by 745.2% (from $19.36 million to $163.63 million).
- The most recent figure is from Definitive Healthcare Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: